tradingkey.logo

Zynex Inc

ZYXI

1.550USD

0.000
Close 09/19, 16:00ETQuotes delayed by 15 min
47.55MMarket Cap
25.22P/E TTM
More Details of Zynex Inc Company
Zynex, Inc. develops, manufactures, markets and sells medical devices used for pain management and rehabilitation, as well as non-invasive fluid, sepsis and laser-based pulse oximetry monitoring systems for use in hospitals. The Company’s devices are intended for pain management to reduce reliance on medications and provide rehabilitation and increased mobility through the utilization of non-invasive muscle stimulation, electromyography technology, interferential current, neuromuscular electrical stimulation and transcutaneous electrical nerve stimulation. The Company’s products include Zynex Medical Products, which includes NexWave, NeuroMove, InWave, E-Wave and M-Wave; Private Labeled Supplies, which includes Electrodes and Batteries; Distributed Complementary, which includes Comfortrac/Saunders, JetStream/Pain Management Technologies, LSO Back Braces and Bracing, and Zynex Monitoring Solutions Products, which includes CM-1500, CM-1600, NiCO CO-Oximeter and HemeOx tHb Oximeter.
Company Info
Ticker SymbolZYXI
Company nameZynex Inc
IPO dateNov 27, 2002
CEOMr. Steven Lewis Dyson
Number of employees1000
Security typeOrdinary Share
Fiscal year-endNov 27
Address9655 Maroon Circle
CityENGLEWOOD
Stock exchangeNASDAQ Global Select Consolidated
CountryUnited States of America
Postal code80112
Phone18004956670
Websitehttps://www.zynex.com/
Ticker SymbolZYXI
IPO dateNov 27, 2002
CEOMr. Steven Lewis Dyson
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Thomas Sandgaard
Mr. Thomas Sandgaard
Chairman of the Board
Chairman of the Board
14.31M
-10.72%
Mr. Barry D. Michaels
Mr. Barry D. Michaels
Independent Director
Independent Director
83.33K
+13.64%
Mr. Michael D. Cress
Mr. Michael D. Cress
Independent Director
Independent Director
83.33K
+13.64%
Ms. Anna Lucsok
Ms. Anna Lucsok
Chief Operating Officer
Chief Operating Officer
50.27K
+7.96%
Mr. Quinn Callanan
Mr. Quinn Callanan
IR Contact Officer
IR Contact Officer
--
--
Mr. Joshua R. (Josh) Disbrow
Mr. Joshua R. (Josh) Disbrow
Independent Director
Independent Director
--
--
Mr. Vikram Singh Bajaj
Mr. Vikram Singh Bajaj
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
--
--
Mr. John T. Bibb
Mr. John T. Bibb
Chief Legal Officer, Company Secretary
Chief Legal Officer, Company Secretary
--
--
Mr. Steven Lewis Dyson
Mr. Steven Lewis Dyson
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Thomas Sandgaard
Mr. Thomas Sandgaard
Chairman of the Board
Chairman of the Board
14.31M
-10.72%
Mr. Barry D. Michaels
Mr. Barry D. Michaels
Independent Director
Independent Director
83.33K
+13.64%
Mr. Michael D. Cress
Mr. Michael D. Cress
Independent Director
Independent Director
83.33K
+13.64%
Ms. Anna Lucsok
Ms. Anna Lucsok
Chief Operating Officer
Chief Operating Officer
50.27K
+7.96%
Mr. Quinn Callanan
Mr. Quinn Callanan
IR Contact Officer
IR Contact Officer
--
--
Mr. Joshua R. (Josh) Disbrow
Mr. Joshua R. (Josh) Disbrow
Independent Director
Independent Director
--
--
Revenue Breakdown
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2023
FY2022
FY2021
No Data
By RegionUSD
Name
Revenue
Proportion
United States
26.58M
0.00%
By Business
By Region
No Data
Shareholding Stats
Updated: Tue, Aug 19
Updated: Tue, Aug 19
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Sandgaard (Thomas)
47.24%
The Vanguard Group, Inc.
3.13%
Two Sigma Investments, LP
1.71%
BlackRock Institutional Trust Company, N.A.
1.67%
Janney Montgomery Scott LLC
1.45%
Other
44.80%
Shareholders
Shareholders
Proportion
Sandgaard (Thomas)
47.24%
The Vanguard Group, Inc.
3.13%
Two Sigma Investments, LP
1.71%
BlackRock Institutional Trust Company, N.A.
1.67%
Janney Montgomery Scott LLC
1.45%
Other
44.80%
Shareholder Types
Shareholders
Proportion
Individual Investor
48.31%
Investment Advisor
7.08%
Hedge Fund
5.13%
Investment Advisor/Hedge Fund
3.57%
Research Firm
2.49%
Venture Capital
0.06%
Other
33.36%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
311
21.33M
70.41%
-5.95M
2025Q1
324
21.34M
70.57%
-6.08M
2024Q4
334
24.74M
77.69%
-3.41M
2024Q3
331
25.30M
79.66%
-3.32M
2024Q2
334
26.14M
82.22%
-2.87M
2024Q1
344
26.41M
82.67%
-3.54M
2023Q4
343
26.23M
77.32%
-4.18M
2023Q3
329
26.70M
74.31%
-5.97M
2023Q2
335
29.53M
80.56%
-2.04M
2023Q1
333
27.95M
76.25%
-3.19M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Sandgaard (Thomas)
14.31M
47.33%
-1.72M
-10.72%
Mar 18, 2025
The Vanguard Group, Inc.
1.05M
3.47%
-11.28K
-1.06%
Mar 31, 2025
Two Sigma Investments, LP
272.03K
0.9%
+68.89K
+33.91%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
1.09M
3.6%
-9.59K
-0.87%
Mar 31, 2025
Janney Montgomery Scott LLC
149.04K
0.49%
-10.22K
-6.41%
Mar 31, 2025
Arrowstreet Capital, Limited Partnership
258.19K
0.85%
--
--
Mar 31, 2025
Geode Capital Management, L.L.C.
387.00K
1.28%
-56.02K
-12.65%
Mar 31, 2025
Renaissance Technologies LLC
150.26K
0.5%
+12.90K
+9.39%
Mar 31, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
KeyAI